Earnings Release: DocuSign, Inc. is set to release its second-quarter earnings on September 4, with analysts predicting earnings of 85 cents per share and revenue of $780.59 million.
Analyst Ratings: Recent analyst ratings show mixed sentiments, with price targets being cut by several firms, including Wedbush and Citigroup, while maintaining various ratings from Neutral to Buy.
DOCU
$67.58+Infinity%1D
Analyst Views on DOCU
Wall Street analysts forecast DOCU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DOCU is 97.62 USD with a low forecast of 80.00 USD and a high forecast of 124.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
Wall Street analysts forecast DOCU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DOCU is 97.62 USD with a low forecast of 80.00 USD and a high forecast of 124.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
10 Hold
0 Sell
Moderate Buy
Current: 68.190
Low
80.00
Averages
97.62
High
124.00
Current: 68.190
Low
80.00
Averages
97.62
High
124.00
Baird
Neutral
downgrade
$90 -> $75
2025-12-05
Reason
Baird
Price Target
$90 -> $75
2025-12-05
downgrade
Neutral
Reason
Baird lowered the firm's price target on DocuSign to $75 from $90 and keeps a Neutral rating on the shares. The firm updated its model following solid Q3 results but awaiting a greater IAM lift in 2027.
Wedbush
Daniel Ives
Neutral
downgrade
$85 -> $75
2025-12-05
Reason
Wedbush
Daniel Ives
Price Target
$85 -> $75
2025-12-05
downgrade
Neutral
Reason
Wedbush analyst Daniel Ives lowered the firm's price target on DocuSign to $75 from $85 and keeps a Neutral rating on the shares. The firm notes the company reported its Q3 results featuring beats across the board as the company saw strong demand for IAM and eSignature, but the performance will be overshadowed by the relatively conservative outlook.
JPMorgan
Mark Murphy
Neutral
downgrade
$80 -> $78
2025-12-05
Reason
JPMorgan
Mark Murphy
Price Target
$80 -> $78
2025-12-05
downgrade
Neutral
Reason
JPMorgan analyst Mark Murphy lowered the firm's price target on DocuSign to $78 from $80 and keeps a Neutral rating on the shares. The firm says the company's outperformance in fiscal Q3 shows its business is on track.
Evercore ISI
In Line -> Hold
downgrade
$92 -> $80
2025-12-05
Reason
Evercore ISI
Price Target
$92 -> $80
2025-12-05
downgrade
In Line -> Hold
Reason
Evercore ISI lowered the firm's price target on DocuSign to $80 from $92 and keeps an In Line rating on the shares. DocuSign delivered "a solid quarter," with revenue and EPS both exceeding expectations, but some moving parts, such as timing-related impacts, "suggest a cautious outlook for the near term," the analyst tells investors.
About DOCU
DocuSign, Inc. provides intelligent agreement management (IAM) platform an eSignature solution, and contract lifecycle management (CLM) solution - allow organizations to increase productivity, accelerate contract review cycles, and transform agreement data into insights and actions. The Company’s IAM platform automates agreement workflows, uncovers actionable insights, and leverages artificial intelligence (AI) capabilities, enabling organizations to create, commit, and manage agreements virtually. Its products include eSignature, CLM, IAM Apps, and Add-on Products. Its Add-on Products include Payments to collect payments along with signed agreements; Identity and standards-based signature for enhanced signer-identification and signatures with digital certification; Notary for remote online notarization; Monitor for advanced analytics; Gen for Salesforce for automated agreement generation within Salesforce, among others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
